Underlying Autoimmune Disease Is Not a Contraindication to the Use of Ipilimumab

JAMA Oncology - United States
doi 10.1001/jamaoncol.2015.4717
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)


Related search